Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
Clin Rheumatol. 2012 Mar;31(3):435-40. doi: 10.1007/s10067-011-1857-4. Epub 2011 Oct 7.
We studied the levels of miR-146a and miR-155 in the urine sediment of SLE patients. The levels of miR-146a and miR-155 in the urine sediment of 40 SLE patients who were receiving calcitriol treatment and 13 healthy controls were determined with real-time quantitative polymerase chain reaction. The levels of urinary miR-146a and miR-155 in patients with SLE were significantly higher than that in healthy controls. Calcitriol treatment reduced the levels of urinary miR-155 in patients with SLE. The level of urinary miR-146a significantly correlated with estimated glomerular filtration rate (r = 0.242, P = 0.008). The level of urinary miR-155 significantly correlated with proteinuria (r = 0.407, P < 0.001) and systemic lupus erythematosus disease activity index (r = 0.278, P = 0.002). The level of urinary miR-146a reversely correlated with the urinary expression of TNF-α (r = -0.247, P = 0.012). Our results suggested that miR-146a and miR-155 might play important roles in the pathophysiology of SLE and the levels of urinary miR-146a and miR-155 could be used as potential markers for diagnosis, disease activity, and therapeutic response.
我们研究了 miR-146a 和 miR-155 在系统性红斑狼疮(SLE)患者尿沉渣中的水平。采用实时定量聚合酶链反应(PCR)检测 40 例接受骨化三醇治疗的 SLE 患者和 13 例健康对照者尿沉渣中 miR-146a 和 miR-155 的水平。SLE 患者尿中 miR-146a 和 miR-155 的水平明显高于健康对照组。骨化三醇治疗降低了 SLE 患者尿中 miR-155 的水平。尿 miR-146a 水平与估计肾小球滤过率(eGFR)显著相关(r=0.242,P=0.008)。尿 miR-155 水平与蛋白尿(r=0.407,P<0.001)和系统性红斑狼疮疾病活动指数(SLEDAI)(r=0.278,P=0.002)显著相关。尿 miR-146a 水平与尿 TNF-α 的表达呈负相关(r=-0.247,P=0.012)。我们的结果表明,miR-146a 和 miR-155 可能在 SLE 的病理生理学中发挥重要作用,尿 miR-146a 和 miR-155 的水平可作为潜在的诊断、疾病活动和治疗反应的标志物。